MSOSLOW/Orl

Status

Available to order

EMMA IDEM:04845
Citation informationRRID:IMSR_EM:04845 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameMSOSLOW/Orl
Alternative nameMSO-Slow
Strain typeSpontaneous
Allele/Transgene symbolMSO-Slow
Gene/Transgene symbolMSO-Slow

Information from provider

ProviderJean-François Cloix
Provider affiliationNeurobiology Laboratory, University of Orleans
Genetic informationGenetic selection of MSO-Slow mice based upon their very long latency toward seizures by injection of a single dose of 75 mg/kg methionine sulfoximine. The selection was performed on genetic random crosses of eight inbred mouse strains: ABP/Le, A/J, BALB/c, C3H/HeJ, C57BL/6J, CBA/H, DBA/2J and SWXL-4.
Phenotypic informationMSO-Slow line is characterized by 1) a very long latency and a very low susceptibility toward seizures upon injection of methionine sulfoximine; 2) low susceptibility to kainic acid and MK-801; 3) an increase in brain glycogen content induced by methionine sulfoximine; 4) involvement of 5-HT in seizures and brain glycogen content. This line has its counterpart as the MSO-Fast mice.
Breeding historyRandom crosses of eight inbred mouse strains: ABP/Le, A/J, BALB/c, C3H/HeJ, C57BL/6J, CBA/H, DBA/2J and SWXL-4 to generate G1. G1 was challenged by a single ip injection of 75 mg/kg methionine sulfoximine and selected upon latency to methionine sulfoximine induced seizures. Mice having the longest latency were inter-crossed without brother-sister crosses. This challenge was repeated for 10 generations, reaching the point where the phenotype was considered as fixed. Then crossing sisters with brothers for 8 generations to perform inbreeding.
References
  • Selection of two lines of mice based on latency to onset of methionine sulfoximine seizures.;Cloix Jean-François, Tahi Zahir, Martin Benoît, Hévor Tobias, ;2010;Epilepsia;51;118-28; 20015245
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredyes
Immunocompromisedno

Information from EMMA

Archiving centreCNRS-TAAM – Typing and Archiving of Animal Models, Orléans, France
Animals used for archivinghomozygous males, homozygous females
Breeding at archiving centreStrain with no genotyping

Literature references

  • Selection of two lines of mice based on latency to onset of methionine sulfoximine seizures.;Cloix Jean-François, Tahi Zahir, Martin Benoît, Hévor Tobias, ;2010;Epilepsia;51;118-28; 20015245

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).